Molecular Monitoring of NPM1 Is a Useful Tool for Detecting Early-Stage Relapse and to Guide Pre-Emptive Treatment Approaches in Patients with NPM1-Mutated Acute Myeloid Leukemia
Author:
Francesca Schieppati,Angela Passi,Erika Borlenghi,Cinzia Lamorgese,Giuseppina Ruggeri,Marco Chiarini,Viviana Giustini,Michele Malagola,Chiara Cattaneo,Margherita Sciumé,Giuseppe Rossi
Copyright © 2017 American Society of Hematology